FindTrial
Sign In

A double blinded randomized trial to see if the use of modified ultrafiltration during surgery effects post-operative recovery course in patients undergoing surgery for congenital heart defects.

A double blinded randomized controlled trial to study the impact of modified ultrafiltration on post-operative course in patients undergoing surgery for congenital heart defects. - MUF STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010512
Enrollment
40
Registered
2017-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q243- Pulmonary infundibular stenosis

Interventions

Intervention1: Modified Ultrafiltration(Muf): In cardiac surgery, after the termination of cardiopulmonary bypass , blood from arterial cannula is pumped through a hemofilter and transfused back into

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with undergoing cardiac surgery for congenital cardiac defects with weight less than 20 kgs 2.Patients with cardiopulmonary bypass time more than 45 minutes

Exclusion criteria

Exclusion criteria: 1.Patients with other non-cardiac comorbidities which might influence or confound the outcome variables a.Coagulopathies b.Children with respiratory compromise pre-operatively c.Haemolytic anaemia d.Sepsis e.Previous sternotomy (redo procedures) f.Patients undergoing emergency/palliative procedures (shunt procedures) 2.Parents/guardians not willing to give consent to participate in this study

Design outcomes

Primary

MeasureTime frame
Improvement in haematocritTimepoint: During the period of admission to the hospital—

Secondary

MeasureTime frame
1.Improvement in cardiac function / ejection fraction 2.Reduction in duration of mechanical ventilation 3.Improvement in systolic BP 4.Reduction in right atrial pressures 5.Reduction in number of blood products used 6.Reduction in use of inotropes Timepoint: During the period of admission to the hospital—

Countries

India

Contacts

Public ContactDr Sujith NS

All India Institute of Medical Sciences, New Delhi

sachintalwar@hotmail.com9868398136

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 14, 2026